Harry J. Leonhardt

Harry J. Leonhardt is a declared insider at 4 companies (senior executive); the most frequent names are Halozyme Therapeutics, Inc., Senomyx Inc and Amylin Pharmaceuticals Inc. In total, 59 filings cover trades dated from 15 February 2006 to 8 January 2025.

Sales make up the whole of the open-market record (21 sales, €618k). Other entries cover 22 share grants and 10 option exercises.

The record was last updated on 8 January 2025 with a transaction in Poseida Therapeutics, Inc. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.